Simplex Trading’s Autolus Therapeutics AUTL Stock Holding History

Simplex Trading’s Portfolio AUTL Stock Details AUTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,800	Closed	-$6K	–	8510
2025 Q3	$6K	Hold	3,800	–	–	﹤0.01%	8154
2025 Q2	$8K	Sell	3,800 -1,300	-25%	-$2.15K	﹤0.01%	7440
2025 Q1	$7K	Sell	5,100 -20,900	-80%	-$42.4K	﹤0.01%	7286
2024 Q4	$61K	Buy	26,000 +17,400	+202%	+$58.8K	﹤0.01%	5661
2024 Q3	$31K	Buy	8,600 +8,300	+2,767%	+$33.1K	﹤0.01%	6317
2024 Q2	$1K	Sell	300 -8,700	-97%	-$37.5K	﹤0.01%	8411
2024 Q1	$57K	Buy	+9,000	New	+$56.1K	﹤0.01%	6133
2022 Q4	–	Sell	-500	Closed	-$1K	–	9174
2022 Q3	$1K	Buy	+500	New	+$1.48K	﹤0.01%	9481
2022 Q2	–	Sell	-2,500	Closed	-$10K	–	9910
2022 Q1	$10K	Buy	2,500 +2,300	+1,150%	+$9.67K	﹤0.01%	8845
2021 Q4	$1K	Buy	+200	New	+$1.2K	﹤0.01%	10136

Other funds holding AUTL

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

TAM

TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Simplex Trading's AUTL Position: Q1 2026 in Review

Simplex Trading reduced its Autolus Therapeutics (AUTL) stake by 59% in Q1 2026, selling an estimated $52.1K and leaving 23,641 shares worth $32.6K. The position accounts for ﹤0.01% of the portfolio, ranked #6302.

Simplex Trading first reported a position in AUTL in Q3 2023 and has held it in 10 quarters since. The position peaked at $115K in Q4 2025. 84 funds tracked by Wall St. Rank hold AUTL as of Q1 2026.

Simplex Trading held 23,641 shares of Autolus Therapeutics worth $32.6K as of Q1 2026.
Simplex Trading sold 34,278 Autolus Therapeutics shares in Q1 2026, an estimated $52.1K.
Autolus Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6302 holding.
Simplex Trading first reported a position in Autolus Therapeutics in Q3 2023 and has held it in 10 quarters since.
Simplex Trading's Autolus Therapeutics position peaked at $115K in Q4 2025.
84 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.